These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 32033764)

  • 21. Promising therapies for treatment of nonalcoholic steatohepatitis.
    Noureddin M; Zhang A; Loomba R
    Expert Opin Emerg Drugs; 2016 Sep; 21(3):343-57. PubMed ID: 27501374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation.
    Sourianarayanane A; Arikapudi S; McCullough AJ; Humar A
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):481-487. PubMed ID: 28253211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Massoud O; Charlton M
    Clin Liver Dis; 2018 Feb; 22(1):201-211. PubMed ID: 29128057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
    Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
    J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
    Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
    APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.
    López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP
    Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
    Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis.
    Shi YW; Fan JG
    Clin Mol Hepatol; 2023 Feb; 29(Suppl):S228-S243. PubMed ID: 36521452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of noninvasive tests and liver biopsy in the diagnosis of nonalcoholic fatty liver disease.
    Isabela Andronescu C; Roxana Purcarea M; Aurel Babes P
    J Med Life; 2018; 11(3):243-246. PubMed ID: 30364513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments.
    Ahn SB
    Clin Mol Hepatol; 2023 Feb; 29(Suppl):S150-S156. PubMed ID: 36696960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of liver biopsy in nonalcoholic fatty liver disease.
    Nalbantoglu IL; Brunt EM
    World J Gastroenterol; 2014 Jul; 20(27):9026-37. PubMed ID: 25083076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers.
    Vilar-Gomez E; Chalasani N
    J Hepatol; 2018 Feb; 68(2):305-315. PubMed ID: 29154965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.
    Abdel-Razik A; Mousa N; Shabana W; Refaey M; ElMahdy Y; Elhelaly R; Elzehery R; Zalata K; Arafa M; Elbaz S; Hafez M; Awad M
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):e1-9. PubMed ID: 26469357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver Disease: Nonalcoholic Fatty Liver Disease.
    Cooper J; Baumgartner K; Smith A; St Louis J
    FP Essent; 2021 Dec; 511():29-35. PubMed ID: 34855339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis.
    Fierbinteanu-Braticevici C; Dina I; Petrisor A; Tribus L; Negreanu L; Carstoiu C
    World J Gastroenterol; 2010 Oct; 16(38):4784-91. PubMed ID: 20939106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.
    Yılmaz Y; Kanı HT; Demirtaş CÖ; Kaya E; Sapmaz AF; Qutranji L; Alkayyali T; Batun KD; Batman M; Toy B; Çiftaslan A
    Turk J Gastroenterol; 2019 Oct; 30(10):892-898. PubMed ID: 31258138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.
    Arab JP; Hernández-Rocha C; Morales C; Vargas JI; Solís N; Pizarro M; Robles C; Sandoval D; Ponthus S; Benítez C; Barrera F; Soza A; Riquelme A; Arrese M
    Gastroenterol Hepatol; 2017; 40(6):388-394. PubMed ID: 28359548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Histopathological diagnosis and differential diagnosis of nonalcoholic fatty liver disease].
    Theurer S; Kälsch J; Schwertheim S; Kathemann S; Baba HA
    Pathologe; 2020 Sep; 41(5):434-443. PubMed ID: 32533233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-alcoholic Fatty Liver Disease (NAFLD)--A Review.
    Karim MF; Al-Mahtab M; Rahman S; Debnath CR
    Mymensingh Med J; 2015 Oct; 24(4):873-80. PubMed ID: 26620035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.